Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week Phase 3 studies in patients with moderate to severe plaque psoriasis

被引：0
|
作者：
Kaur, M. [1 ]
Merola, J. [2 ]
Tatulych, S. [3 ]
Mamolo, C. [3 ]
Lan, S. [3 ]
机构：
[1] Pfizer, Collegeville, PA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dermatol, Boston, MA USA
[3] Pfizer, Groton, CT USA
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2016年 / 30卷
关键词：
psoriasis; nails; tofacitinib;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P157
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)
    Saeki, Hidehisa
    Nakagawa, Hidemi
    Nakajo, Ko
    Ishii, Taeko
    Morisaki, Yoji
    Aoki, Takehiro
    Cameron, Gregory S.
    Osuntokun, Olawale O.
    JOURNAL OF DERMATOLOGY, 2017, 44 (04): : 355 - 362
  • [12] Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis
    Tan, Huaming
    Valdez, Hernan
    Griffiths, Chris E. M.
    Mrowietz, Ulrich
    Tallman, Anna
    Wolk, Robert
    Gordon, Kenneth
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (01) : 3 - 7
  • [13] Efficacy and Safety of Apremilast and Switch from Etanercept in Patients with Moderate to Severe Psoriasis: 52-Week Results
    Reich, Kristian
    Soung, Jennifer
    Gooderham, Melinda
    Zhang, Zuoshun
    Nograles, Kristine
    Day, Robert M.
    Ferris, Laura
    Goodfield, Mark
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [14] Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial
    Magnolo, Nina
    Kingo, Kulli
    Laquer, Vivian
    Browning, John
    Reich, Adam
    Szepietowski, Jacek C.
    Keefe, Deborah
    Mazur, Rafal
    Ghelani, Prayashi
    Forrer, Pascal
    Patekar, Manmath
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB119 - AB119
  • [15] Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials
    Menter, M. Alan
    Papp, Kim A.
    Cather, Jennifer
    Leonardi, Craig
    Pariser, David M.
    Krueger, James G.
    Wohlrab, Johannes
    Amaya-Guerra, Mario
    Kaszuba, Andrzej
    Nadashkevich, Oleg
    Tsai, Tsen-Fang
    Gupta, Pankaj
    Tan, Huaming
    Valdez, Hernan
    Mallbris, Lotus
    Tatulych, Svitlana
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (05) : 568 - 580
  • [16] 52-Week efficacy in patients with moderate to severe psoriasis continued on apremilast or switched from etanercept: The LIBERATE study
    Reich, K.
    Papp, K.
    van de Kerkhof, P.
    Zhang, Z.
    Nograles, K.
    Soung, J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 69 - 70
  • [17] BIMEKIZUMAB EFFICACY IN MODERATE TO SEVERE PLAQUE PSORIASIS: IMPROVEMENTS IN FATIGUE OBSERVED IN TWO PHASE 3 STUDIES
    Gottlieb, Alice B.
    Augustin, Matthias
    Lambert, Jo
    Pinter, Andreas
    Savage, Laura J.
    Tsai, Tsen-Fang
    Foley, Peter
    Paul, Carle
    Warham, Rhys
    Lambert, Jeremy
    Wiegratz, Susanne
    Stahle, Mona
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [18] Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
    Gnesotto, Laura
    Mioso, Guido
    Bardazzi, Federico
    Filippi, Federica
    Di Lernia, Vito
    Motolese, Alberto
    Di Nuzzo, Sergio
    Conti, Andrea
    Arginelli, Federica
    Corazza, Monica
    Odorici, Giulia
    Borghi, Alessandro
    Gisondi, Paolo
    Naldi, Luigi
    Dapavo, Paolo
    Parodi, Aurora
    Burlando, Martina
    Piaserico, Stefano
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [19] Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis
    Korman, Abraham M.
    Hill, Dane
    Alikhan, Ali
    Feldman, Steven R.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (04) : 525 - 539
  • [20] Patients with moderate to severe plaque psoriasis show consistently a quick improvement of nail psoriasis
    Schopf, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 193 - 193
12345